Sosei Heptares Revenue and Competitors
Estimated Revenue & Valuation
- Sosei Heptares's estimated annual revenue is currently $35.3M per year.
- Sosei Heptares's estimated revenue per employee is $155,000
Employee Data
- Sosei Heptares has 228 Employees.
- Sosei Heptares grew their employee count by 9% last year.
Sosei Heptares's People
Name | Title | Email/Phone |
---|---|---|
1 | EVP, Chief Staff | Reveal Email/Phone |
2 | VP, Head Discovery | Reveal Email/Phone |
3 | Head Human Resources | Reveal Email/Phone |
4 | Quality Assurance Officer | Reveal Email/Phone |
5 | SVP Corporate Strategy | Reveal Email/Phone |
6 | Head IP | Reveal Email/Phone |
7 | General Counsel | Reveal Email/Phone |
8 | Head Finance | Reveal Email/Phone |
9 | Head Clinical Operations | Reveal Email/Phone |
10 | Head Human Resources | Reveal Email/Phone |
Sosei Heptares Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Sosei Heptares?
We are an international biopharmaceutical group focused on the discovery and early development of new medicines originating from our proprietary GPCR-targeted StaR® technology and structure-based drug design platform capabilities. We are advancing a broad and deep pipeline of novel medicines across multiple therapeutic areas, including neurology, immunology, gastroenterology and inflammatory diseases. We have established partnerships with some of the world's leading pharmaceutical companies, including AbbVie, AstraZeneca, Genentech (Roche), Novartis, Pfizer and Takeda and additionally with multiple emerging technology companies. Sosei Heptares is headquartered in Tokyo, Japan with corporate and R&D facilities in Cambridge, UK. Sosei Heptares is the corporate brand of Sosei Group Corpoation, which is listed on the Tokyo Stock Exchange (ticker: 4565). For more information, please visit www.soseiheptares.com
keywords:N/AN/A
Total Funding
228
Number of Employees
$35.3M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sosei Heptares News
Sosei Heptares to Embed Agile Operating Model and Enhance its Translational Medicine Capabilities through Strategic Collaboration with...
The collaboration aims to build upon Sosei Heptares' world-leading G protein-coupled receptor (GPCR) structure-based drug design (SBDD) platform...
Sosei Heptares has unveiled a raft of senior leadership changes as it focuses on driving growth out of its R&D expertise at Granta Park.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35.3M | 228 | 9% | N/A |
#2 | $88.2M | 243 | 11% | N/A |
#3 | $40.5M | 254 | 9% | N/A |
#4 | $37.3M | 261 | 110% | $260.4M |
#5 | $39.2M | 274 | 40% | N/A |